Russia Lipid Market Size & Outlook, 2022-2030
Russia lipid market, 2018-2030 (US$M)
Related Markets
Russia lipid market highlights
- The Russia lipid market generated a revenue of USD 120.1 million in 2022 and is expected to reach USD 184.9 million by 2030.
- The Russia market is expected to grow at a CAGR of 5.5% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 120.1 million |
| Market revenue in 2030 | USD 184.9 million |
| Growth rate | 5.5% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Russia accounted for 1.3% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany lipid market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 609.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Russia lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.48% in 2022. Horizon Databook has segmented the Russia lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical industry in Russia is expected to be driven by the continuous innovation, research, and development of various drugs on account of increasing production efficiency and improving the quality of the manufactured drugs.
In addition, increasing life expectancy and a growing population are anticipated to boost the pharmaceutical market in the country. Amid the COVID-19 pandemic, the country’s pharmaceutical sector played an important role in uplifting the country’s economy and curbing the spread of COVID-19.
Although Russia imports a majority of its medicines from other countries, increasing in-house production and growing investment in R&D activities are expected to boost the growth of the pharmaceutical sector in the country. Such factors are responsible for the growth of the lipid market in Russia over the forecast period.
Reasons to subscribe to Russia lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Russia lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia lipid market , including forecasts for subscribers. This country databook contains high-level insights into Russia lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Russia lipid market size, by phase, 2018-2030 (US$M)
Russia Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
